Working Bibliography
1) Barker, Phil, and Poppy Buchanan-Barker. "First, Do No Harm: Confronting The Myths Of Psychiatric Drugs." Nursing Ethics 19.4 (2012): 451-463. Academic Search Premier. Web. 16 Apr. 2013.
Abstract Summary: “The enduring psychiatric myth is that particular personal, interpersonal and social problems in living are manifestations of ‘mental illness’ or ‘mental disease’, which can only be addressed by ‘treatment’ with psychiatric drugs. Psychiatric drugs are used only to control ‘patient’ behavior and do not ‘treat’ any specific pathology in the sense understood by physical medicine. Evidence that people, diagnosed with ‘serious’ forms of ‘mental illness’ can ‘recover’, without psychiatric drugs, has been marginalized by drug-focused research, much of this funded by the pharmaceutical industry. The pervasive myth of psychiatric drugs dominates much of contemporary ‘mental health’ policy and practice and raises discrete ethical issues for nurses who claim to be focused on promoting or enabling the ‘mental health’ of the people in their care.” [ABSTRACT FROM AUTHOR] .
2) Breggin, P. R. (1991). Toxic Psychiatry. New York: St. Martins Press.
Summary (From Book): “In this searing, myth-shattering exposé, psychiatrist Peter R. Breggin, M.D., breaks through the hype and false promises surrounding the "New Psychiatry" and shows how dangerous, even potentially brain-damaging, many of its drugs and treatments are. He asserts that: psychiatric drugs are spreading an epidemic of long-term brain damage; mental "illnesses" like schizophrenia, depression, and anxiety disorder have never been proven to be genetic or even physical in origin, but are under the jurisdiction of medical doctors; millions of schoolchildren, housewives, elderly people, and others are labeled with medical diagnoses and treated with authoritarian interventions, rather than being patiently listened to, understood, and helped. Toxic Psychiatry sounds a passionate, much-needed wake-up call for everyone who plays a part, active or passive, in America's ever-increasing dependence on harmful psychiatric drugs.”
This book is amazing, and full of true stories to refer back to. A Psychiatrist letting out all of the dark secrets.
3) Critser, G. (2005). Generation Rx: how prescription drugs are altering American lives, minds, and bodies. New York: Houghton Mifflin Company.
Summary (From Book): “Greg Critser's brilliantly incisive Generation Rx shows how shockingly little we know about the prescription drugs we take and the hazards they may pose to our health. Americans are prescribed more drugs today than ever before, and the pharmaceutical industry has gained tremendous financial power and political clout. Drawing on exclusive access to the strategists, scientists, and current and former heads of GlaxoSmithKline, Eli Lilly, Merck, and other drug giants, Critser chronicles the transformation of big pharma from onetime lumbering medical conglomerate to media-savvy consumer enterprise. He also reveals the direct and indirect consequences for our health, among them increased incidence of damage to major organs, unprecedented medication use by the very young and very old, and the emergence of polypharmacy, in which various drugs taken together can unleash unanticipated, and often deadly, effects. Generation Rx urges all of us to think about the price we pay, as a society and with our own bodies, for our chronic use of prescription drugs.”
4) Docksai, Rick. "Long-Term Risks Of Psychiatric Drugs." Futurist 47.3 (2013): 12-14. Academic Search Premier. Web. 22 Apr. 2013.
Abstract Summary: “The article discusses research into the long term side effects of psychiatric drugs such as antidepressants and antipsychotics. Brain and body chemistry changes, drug prescriptions in the U.S. and Great Britain, and issues such as over prescription are discussed, as well as the attitudes of psychiatrists such as Richard Friedman and Peter Breggin. Side effects such as brain-tissue shrinkage, bone fractures, and tardive dyskinesia are discussed, as well as quality of life considerations for mentally ill people.” [ABSTRACT FROM AUTHOR]
I will use this article a lot for my paper because it refers to Breggin, Author of Toxic Psychiatry (repetition!!!) and is about “Over prescription” which is one of the main arguments for my paper.
5) Goldman, David Eckstein. "Mental Illness, Medicine And Law." Journal Of Legal Medicine 31.1 (2010): 163-170. Academic Search Premier. Web. 22 Apr. 2013.
Abstract Summary:
“The article reviews the book "Mental Illness, Medicine and Law," edited by Martin Lyon Levine.” [ABSTRACT FROM AUTHOR]
This article is full of the legal terminology needed for my research paper to be sound.
6) Gottstein, James B. "Ethical And Moral Obligations Arising From Revelations Of Pharmaceutical Company Dissembling." Ethical Human Psychology & Psychiatry 12.1 (2010): 22-29. Academic Search Premier. Web. 16 Apr. 2013.
Abstract Summary: “The article reports on pharmaceutical companies' fraud and manipulation and their impact on psychiatrists, psychologists, and social workers' ethical obligation. U.S. Senator Charles Grassley has reportedly exposed psychiatric opinion leaders for secretly and illegally taking large sums of money from drug companies in exchange for promoting their psychiatric drugs. The author provides a list of those involved, and concludes that psychiatrists, psychologists and social workers are ethically obliged to lead the way toward stopping the fraud.” [ABSTRACT FROM AUTHOR] .
7) Grekin, Emily R. et al. "Psychotropic Drug Use Among College Students: Patterns Of Use, Misuse, And Medical Monitoring." Journal Of American College Health 59.7 (2011): 658-661. Academic Search Premier. Web. 22 Apr. 2013.
Abstract Summary: “Objective: To assess whether college students who use psychotropic drugs are (1) aware of potential side effects, (2) appropriately monitored by prescribing physicians, and (3) taking medications as prescribed. Participants: Fifty-five college students, currently taking psychotropic medications, were recruited between Summer 2008 and Fall 2009. Methods: Participants were given interviews assessing (1) interactions with prescribing physicians, (2) patterns of psychotropic drug use, and (3) Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) substance use disorders. Results: Twenty-five percent of participants did not remember being assessed for suicidal ideation. A large number of participants took their medications in different quantities or frequencies than prescribed and 35% of participants met DSM criteria for substance dependence. Conclusions: Many students are misusing psychotropic medications and this misuse is not being communicated with prescribing physicians.” [ABSTRACT FROM AUTHOR] .
8) Hagen, Brad F., Gary Nixon, and Tracey Peters. "The Greater Of Two Evils? How People With Transformative Psychotic Experiences View Psychotropic Medications." Ethical Human Psychology & Psychiatry 12.1 (2010): 44-59. Academic Search Premier. Web. 22 Apr. 2013.
Abstract Summary: “The article reports on a qualitative study that shows the potentially transformational nature of psychotropic medication. Some participants interviewed believe psychotropics should be used only in crisis situations, while others speak of the drugs' considerable limitations or say their use is never justified. Reports of physical, cognitive, emotional, and spiritual harm are made. Practitioners are encouraged to study the literature on the lack of actual effectiveness and side effects of the drugs. Data analysis and ethical considerations are taken up.”
9) Herzberg, D. (2009). Happy Pills in America: From Miltown to Prozac. Baltimore: Johns Hopkins University Press.
Summary (From Book): “David Herzberg addresses these questions by tracing the rise of psychiatric medicines, from Miltown in the 1950s to Valium in the 1970s to Prozac in the 1990s. The result is more than a story of doctors and patients. From bare-knuckled marketing campaigns to political activism by feminists and antidrug warriors, the fate of psychopharmacology has been intimately wrapped up in the broader currents of modern American history. Beginning with the emergence of a medical marketplace for psychoactive drugs in the postwar consumer culture, Herzberg traces how "happy pills" became embroiled in Cold War gender battles and the explosive politics of the "war against drugs"—and how feminists brought the two issues together in a dramatic campaign against Valium addiction in the 1970s. A final look at antidepressants shows that even the Prozac phenomenon owed as much to commerce and culture as to scientific wizardry. With a barrage of "ask your doctor about" advertisements competing for attention with shocking news of drug company malfeasance, Happy Pills is an invaluable look at how the commercialization of medicine has transformed American culture since the end of World War II.”
This book is important because the 1950’s right after WWII is when Psychiatry really took off. I will be using this book for a history of what it used to be and how much it has increased today.
10) HORGAN, JOHN. "Are Psychiatric Medications Making Us Sicker?." Chronicle Of Higher Education 58.5 (2011): B4-B5. Academic Search Premier. Web. 22 Apr. 2013.
Abstract Summary: “In this article the author discusses psychiatric medicines and examines the possibility that medical treatment for mental illnesses such as depression, bipolarity, schizophrenia, and anxiety disorder may do more harm than good. He comments on his research regarding the limited medical evidence regarding the effectiveness of medications such as selective serotonin reuptake inhibitors (SSRIs), tricyclics, and monoamine oxidase inhibitors and the possibility of collusive behavior between the pharmaceutical industry and psychiatrists to promote the use of psychotropic drugs. He also analyzes research published in the book "Anatomy of an Epidemic" by Robert Whitaker regarding the negative effects of SSRIs and the attention-deficit disorder medication Ritalin.”
This is another article I believe I will look to more because it repeats the argument I will be trying to make in my paper.
11) Jackson, Catherine. "Diagnostic Disarray." Therapy Today 23.3 (2012): 4-8. Academic Search Premier. Web. 22 Apr. 2013.
Abstract Summary: “The article reports the conflict that has been created by the decision of the American Psychiatry Association's proposed fifth revision of the "Diagnostic and Statistical Manual of Mental Disorders" (DSM-5). A main reason attributed for criticism of the draft is the application of psychiatric diagnoses to an even larger number of normal ranges of human emotions and behaviors. Two new diagnoses highlighted in DSM-5 are oppositional defiant disorder and premenstrual dysphoric disorder. INSET: If the symptoms fit.....”
The subject of the DSM-5 is very big in the medical community because it is what Psychiatrists use to diagnose illnesses they then prescribe psychotropic drugs for.
12) Making a Killing: The Untold Story of Psychotropic Drugging: A Documentary Film. 2000. DVD. Citizens Commission on Human Rights. 2000.
13) ---Psychiatry: An Industry of Death: A Documentary Film. 2010. DVD.
Summary: "Psychotropic drugs. It's the story of big money-drugs that fuel a $330 billion psychiatric industry, without a single cure. The cost in human terms is even greater-these drugs now kill an estimated 42,000 people every year. And the death count keeps rising. Containing more than 175 interviews with lawyers, mental health experts, the families of victims and the survivors themselves, this riveting documentary rips the mask off psychotropic drugging and exposes a brutal but well-entrenched money-making machine."
This documentary is what spiked my interest in the topic for my paper. I will watch it again and get more ideas.
14) Maj, Mario. "Financial And Non-Financial Conflicts Of Interests In Psychiatry." European Archives Of Psychiatry & Clinical Neuroscience 260.(2010): 147-151. Academic Search Premier. Web. 17 Apr. 2013.
Abstract Summary: “Conflict of interests occurs when a doctor is unduly influenced by a secondary interest (i.e., a personal incentive) in his acts concerning one of the primary interests to which he is professionally committed (the welfare of patients, the progress of science, or the education of students or residents). One specific variety of conflicts of interests has monopolized the attention of the scientific and lay press: the financial conflicts of interests arising from the relationships between doctors and drug companies. A large literature has described the many, sometimes subtle, ways by which a psychiatrist can be influenced in his prescribing habits or research activities by his relationships with the industry. Some empirical evidence is now available in this area. On the other hand, it has been pointed out that the current debate on this issue is sometimes 'affectively charged' or fails to take into account that the interests of patients, families and mental health professionals and those of the industry may be often convergent. Other types of conflicts of interests are beginning now to be discussed. There is evidence that the allegiance of a researcher to a given school of thought may influence the results of studies comparing different psychotherapeutic techniques, thus colliding with the primary interest represented by the progress of science. Political commitment is also emerging as a source of conflicts of interests. Financial and non-financial conflicts of interests are widespread in psychiatric practice and research. They cannot be eradicated, but must be managed more effectively than is currently the case.” [ABSTRACT FROM AUTHOR]
Conflicts of interest between the drug companies, the FDA, and the Doctors will be a large portion of my research paper. This is an important article for that.
15) Rudorfer, Matthew V., and Mi Hillefors. "Assessing Psychiatric Adverse Effects During Clinical Drug Development." Pharmaceutical Medicine - New Zealand 26.6 (2012): 363-394. Academic Search Premier. Web. 22 Apr. 2013.
Abstract Summary: “Going forward, translational research holds the promise of better understanding of the biological and genetic underpinnings of these severe psychiatric adverse effects. Complementing this progress in the laboratory are advances in clinical and regulatory practice, most notably, the growing availability of electronic medical records and increasing harmonization of approach of drug regulatory bodies across countries. Together, these trends hold promise for a more complete appreciation of, and response to, threats posed to the benefit: risk of pharmacotherapy by medications with undesirable adverse effects, including those in the psychiatric as well as physical health spheres” [ABSTRACT FROM AUTHOR]
16) Saniotis, Arthur. "Evolutionary And Anthropological Approaches Towards Understanding Human Need For Psychotropic And Mood Altering Substances." Journal Of Psychoactive Drugs 42.4 (2010): 477-484. Academic Search Premier. Web. 22 Apr. 2013.
Abstract Summary: “Human addiction to psychotropic and mood altering substances is an ongoing international problem. While the phenomenon of psychoactive drug use has received considerable theoretical attention there need to be more comparative approaches into this area. Evolutionary and anthropological approaches for understanding human need for psychotropic and mood altering substances offer the reader various insightful angles for analyzing this phenomenon. While evolutionary approaches investigate the evolutionary behaviors and mechanisms of human ancestral psychotropic use, anthropological approaches emphasize the social and religious meanings of individual drug use. While each approach proffers different ideas, a comparative approach, which is utilized in this study, may provide a novel and invaluable insight for understanding human need for psychotropic and mood-altering substances.”[ABSTRACT FROM PUBLISHER] .
This Article is particularly interesting because it goes into the addiction people have today with “Needing” drugs for normal feelings basically.
17) Sharav, Vera Hassner. "Screening For Mental Illness: The Merger Of Eugenics And The Drug Industry." Ethical Human Psychology & Psychiatry 7.2 (2005): 111-124. Academic Search Premier. Web. 16 Apr. 2013.
Abstract Summary: “The implementation of a recommendation by the President's New Freedom Commission (NFC) to screen the entire United States population--children first--for presumed, undetected, mental illness is an ill-conceived policy destined for disastrous consequences. The "pseudoscientific" methods used to screen for mental and behavioral abnormalities are a legacy from the discredited ideology of eugenics. Both eugenics and psychiatry suffer from a common philosophical fallacy that undermines the validity of their theories and prescriptions. Both are wed to a faith-based ideological assumption that mental and behavior manifestations are biologically determined, and are, therefore, ameliorated by biological interventions. NFC promoted the Texas Medication Algorithm Project (TMAP) as a "model" medication treatment plan. The impact of TMAP is evident in the skyrocketing increase in psychotropic drug prescriptions for children and adults, and in the disproportionate expenditure for psychotropic drugs. The New Freedom Commission's screening for mental illness initiative is, therefore, but the first step toward prescribing drugs. The escalating expenditure for psychotropic drugs since TMAP leaves little doubt about who the beneficiaries of TMAP are. Screening for mental illness will increase their use.” [ABSTRACT FROM AUTHOR]
18) Stein, David B., and Robert Foltz. "The Need To Operationally Define "Disease" In Psychiatry And Psychology." Ethical Human Psychology & Psychiatry 11.2 (2009): 120-141. Academic Search Premier. Web. 16 Apr. 2013.
Abstract Summary: “A universally accepted operational definition for the term "disease" is not yet established in contemporary psychiatry. In clinical psychology and psychiatry, disease has been used indiscriminately. The term disease has been invoked (even when no systemic etiology or pathology has existed) to describe addictions, a cluster of bizarre symptoms, and to justify crude medically based treatments (e.g., electroshock, lobotomy, involuntary commitment, medication prescription). More recently, sophisticated machines such as CAT scans, PET scans, and MRIs have been used for questionable research conducted to try to identify supposed diseases, to justify the overuse of psychotropic drugs. Economic and industry interests have superseded scientific concerns. To establish scientific rigor in psychiatry and clinical psychology research, an operational definition of disease is proposed.”[ABSTRACT FROM AUTHOR]
19) Sullivan, H. S. (2012). Conceptions of Modern Psychiatry: The first William Alanson White Memorial Lectures. Psychiatry: Interpersonal & Biological Processes, 3-17.
Abstract Summary: “The role of William Alanson White in the last four decades of American psychiatry was great indeed. To most of his students, the Professor was American psychiatry and a kindly benevolent father. In psychiatry he was a leader, a champion of progressive developments. He was a calm influence at the conference table and a wise counselor to those with whom he collaborated. In medicine, he was the foremost exponent of the doctrine of the Organism-as-a-whole. He was an integrator of constructive emergent in the field of the social sciences. He correlated divers scientific insights in the service of understanding human behavior. In the family, the community, and in the counsels of legislator and executive, he was a tireless proponent of the wise dissemination of psychiatry. His purpose and the purposes of psychiatry were one. Educator, collaborator, integrator, investigator humanitarian; he was a stimulus to great achievements, an ideal exemplinarian of the doctrine of service.”
20) United States National Institute of Mental Health. U.S. Department of Health and Human Services, 10 Apr 2013. Web. 23 Apr 2013.
Summary: This website is full of publications on my topic of Psychiatry and Psychotropic Drugs. I will refer a lot to this website.